AI
?Will AI invent the first "super drug"
Artificial intelligence technology has entered an unprecedented phase in the medical sector, as Isomorphic Labs, the vital arm of Google DeepMind, announced the imminent start of laboratory and clinical trials for drugs entirely designed by AI.
Artificial intelligence technology has entered an unprecedented phase in the medical sector, as Isomorphic Labs, the vital arm of Google DeepMind, announced the imminent start of laboratory and clinical trials for drugs entirely designed by artificial intelligence. This step comes after the scientific achievement of the company's scientists winning the Nobel Prize in Chemistry.
"AlphaFold" Revolution: How AI Deciphered Proteins?
The new drugs rely on the AlphaFold platform, the technology that revolutionized the understanding of molecular biology:
Protein Prediction: The platform successfully predicted the structure of over 200 million proteins with extreme accuracy, an achievement that would have taken centuries using traditional methods.
Understanding Interactions: The third generation (AlphaFold 3) not only maps the shape of proteins but also predicts how the body and DNA interact with proposed drugs.
Nobel Prize and Drug Design with "Double Effectiveness"
In 2024, the Nobel Committee honored the efforts of Demis Hassabis and John Jumper with the Chemistry Prize, in recognition of AlphaFold's role in accelerating scientific discoveries. Max Jaderberg, CEO of Isomorphic Labs, revealed that the lab now possesses "closed" technologies capable of designing drugs with effectiveness exceeding twice the capability of publicly available engines.
Strategic Partnerships with Pharma Giants
To accelerate the delivery of these drugs to patients, Isomorphic has partnered with major global companies such as:
Eli Lilly.
Novartis. These partnerships focus on developing advanced treatments in the fields of oncology and immunology.
When Will Clinical Trials Begin?
Despite a slight delay from the date previously set by Demis Hassabis (end of last year), Jaderberg confirmed to "Wired" that real tests will begin "very soon." This moment will be the decisive test to prove whether artificial intelligence can not only propose theories but also deliver successful and safe drugs for humans.
Future of Medicine: Personalized Treatments for Incurable Diseases
Artificial intelligence technologies open horizons for an era of "personalized medicine," where it is possible to:
Precisely identify the defect causing the disease with microscopic accuracy.
Design drug molecules that target the disease without harming healthy cells.
Reduce drug development time from years to months.
Conclusion: We are at a historical turning point; if DeepMind's upcoming tests succeed, it will mean that artificial intelligence has transformed from a "research assistant" into an "inventor" of the greatest treatments in human history.
